Skip to main content

Point-of-care testing with Nexus IB10 Analyzer

The CE-IVD marked Nexus IB10 platform is a fully automated rapid immunoassay point-of-care instrument. With a hands-on-time of less than 3 minutes the easy-to-use system provides in only 20 minutes test results for biomarkers that are crucial in the management of critical care patients. After applying the patient sample, the entire test is performed within the Nexus IB10 analyzer which controls the temperature of the disc, as well as the sequence, duration of measurement, centrifugal flow, mixing, incubation, time, final signal measurement, quantitation and reporting of results. The disc also includes a positive internal control to ensure that the test device operates properly. The portfolio of IB10 assays includes tests for established critical care parameters as well as tests for SphingoTec’s proprietary biomarkers such as bio-ADM, and penKid.

Whole Blood use
No sample preparation needed

Time to result 20 minutes
with hands-on time under 3 minutes 

Panel Tests
Up to three analytes tested in a single run

Fast & fully automated
Built-in self-test feature to minimize hands-on maintenance

Portable & user friendly
Compact and easy to move with minimal user interaction

Quantitative Results
Results can be printed or directly transferred to LIMS


Point-of-care diagnostics made easy

Watch our short video tutorial and get more information and insight on our rapid point-of-care platform Nexus IB10.  Learn in only one and a half minutes how the easy-to-use platform provides test results in only 20 minutes for biomarkers that are crucial in the management of critical care patients.

Play Video

IB10 Assays for novel acute care biomarkers

The IB10 assays portfolio includes SphingoTec’s novel proprietary and patented biomarkers for acute care settings: the assay for Bioactive Adrenomedullin (bio-ADM), a biomarker for real-time assessment of endothelial function in conditions like sepsis, and the assay for  Proenkephalin (penKid), a biomarker for real-time assessment of kidney function.

IB10 sphingotest® bio-ADM®

for the quantitative in vitro determination of bioactive Adrenomedullin (bio-ADM)

IB10 sphingotest® penKid®

for the quantitative in vitro determination of Proenkephalin (penKid)

IB10 Assays for established acute care biomarkers

The portfolio of IB10 assays includes a broad range of blood tests and test panels routinely used in EDs and ICUs such as tests for Procalcitonin, Troponin I, CK-MB, Myoglobin, NT-proBNP, and D-Dimer.

IB10 sphingotest® PCT  

for the quantitative in vitro determination of Procalcitonin (PCT) in the concentration range of 0.3 μg/L to 10 μg/L

IB10 sphingotest®
Troponin-99

for the quantitative in vitro determination of Cardiac Troponin I (cTnI)

IB10 sphingotest®
NT-proBNP

for the quantitative in vitro determination of N-terminal pro-brain natriuretic peptide (NT-proBNP)

IB10 sphingotest® D-Dimer

for the quantitative in vitro determination of cross-linked fibrin degradation products containing D-Dimer

IB10 sphingotest® Shortness of Breath

for the quantitative in vitro determination of Cardiac Troponin I (cTnI), N-terminal pro-brain natriuretic peptide (NT-proBNP) and D-Dimer

IB10 sphingotest® 3-in-1 Cardiac

for the quantitative in vitro determination of Cardiac Troponin I (cTnI), Creatine kinase-MB (CK-MB) and Myoglobin

IB10 sphingotest® TSH

for the quantitative in vitro determination of thyroid stimulating hormone (TSH)

IB10 sphingotest® beta-hCG

for the quantitative in vitro determination of human chorionic gonadotropin (hCG)

Request a quote

 Are you a customer or distributor of Nexus IB10? See our full list of IB10 products and stock up your IB10 supply.

Request a Quote

Get in touch with us

Do you have any questions about our services?
Our dedicated Team can help you.
Please fill in the form and we will be in touch with you shortly.


Disclaimer:
Products based on the Nexus IB10 technology (Nexus Dx, Inc., San Diego, CA, USA) described are CE-IVD-marked and hence certified and approved for use in the European Economic Area (EEA) only. Human diagnostic use of such products may be subject to local regulations. Please check for local availability and information on potential EEA-external approvals with the manufacturers.
Caution - The information contained in this communication does not constitute nor imply an offer to sell or transfer any product based on the Nexus IB10 technology as in vitro diagnostic (IVD) product in the United States of America or Canada. No product based on the Nexus IB10 technology is currently available for sale as an IVD product in the United States of America or Canada. The analytical and clinical performance characteristics in compliance with U.S. FDA medical device regulations of any Nexus IB10 product may be sold at some future point in time in the U.S., have not yet been established.